MICHAEL P GOLDSTEIN

Eye and Vision Services Providers|Optometrist ROCKY HILL, CT NPI 1013003615

General Payments — all program years on this page

$2,863.68

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 101
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $478.94 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $478.9420

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $387.6416
SUN PHARMACEUTICAL INDUSTRIES INC. $41.642
Dompe US, Inc. $25.581
Alcon Laboratories Inc $24.081

By program year

Program yearAmountRecords
2018 $473.3116
2019 $948.9028
2020 $134.893
2021 $258.628
2022 $217.9711
2023 $351.0515
2024 $478.9420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1110662853 Alcon Vision LLC $24.08 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666777 Amgen Inc. $13.22 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666783 Amgen Inc. $11.76 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666789 Amgen Inc. $13.27 02/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666797 Amgen Inc. $17.07 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666805 Amgen Inc. $19.49 03/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666816 Amgen Inc. $26.30 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666823 Amgen Inc. $8.36 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666832 Amgen Inc. $9.82 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666843 Amgen Inc. $13.75 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666851 Amgen Inc. $77.72 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666860 Amgen Inc. $11.78 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666868 Amgen Inc. $16.48 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666876 Amgen Inc. $6.82 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666885 Amgen Inc. $6.82 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666893 Amgen Inc. $10.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115666901 Amgen Inc. $124.98 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151411479 Dompe US, Inc. $25.58 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152182817 SUN PHARMACEUTICAL INDUSTRIES INC. $20.89 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152182819 SUN PHARMACEUTICAL INDUSTRIES INC. $20.75 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.